Back to Trades
Struthers Richard Scott
President & CEODirectorCIK 0001746298
Total Volume
$176.6M
5 filings
Purchases
$0
0 buy txns
Sales
$180.0K
1 sell txns
Net Activity
-$180.0K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Struthers Richard Scott, President & CEO, Director, has disclosed $176.6M in transactions — all concentrated in Crinetics Pharmaceuticals, Inc. (CRNX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $180.0K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 1 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Disposed | $174.5M |
| Aug 11 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Exercise | $800.0K |
| Jun 2 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Gift | $0 |
| Dec 18 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Exercise | $1.2M |
| Sep 30 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Sell | $180.0K |
5 filings